Drug Target Group Prediction with Multiple Drug Networks

被引:31
作者
Che, Jingang [1 ]
Chen, Lei [1 ,2 ]
Guo, Zi-Han [1 ]
Wang, Shuaiqun [1 ]
Aorigele [3 ]
机构
[1] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
[2] East China Normal Univ, Shanghai Key Lab PMMP, Shanghai 200241, Peoples R China
[3] Univ Toyama, Fac Engn, Toyama, Japan
基金
上海市自然科学基金;
关键词
Drug-target interaction; drug target group; multiple drug networks; Meka; Mulan; support vector machine; IN-VITRO; IDENTIFICATION; SIMILARITY;
D O I
10.2174/1386207322666190702103927
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Identification of drug-target interaction is essential in drug discovery. It is beneficial to predict unexpected therapeutic or adverse side effects of drugs. To date, several computational methods have been proposed to predict drug-target interactions because they are prompt and low-cost compared with traditional wet experiments. Methods: In this study, we investigated this problem in a different way. According to ICEGG, drugs were classified into several groups based on their target proteins. A multi-label classification model was presented to assign drugs into correct target groups. To make full use of the known drug properties, five networks were constructed, each of which represented drug associations in one property. A powerful network embedding method, Mashup, was adopted to extract drug features from above-mentioned networks, based on which several machine learning algorithms, including RAndom k-labELsets (RAKEL) algorithm, Label Powerset (LP) algorithm and Support Vector Machine (SVM), were used to build the classification model. Results and Conclusion: Tenfold cross-validation yielded the accuracy of 0.839, exact match of 0.816 and hamming loss of 0.037, indicating good performance of the model. The contribution of each network was also analyzed. Furthermore, the network model with multiple networks was found to be superior to the one with a single network and classic model, indicating the superiority of the proposed model.
引用
收藏
页码:274 / 284
页数:11
相关论文
共 56 条
[1]  
[Anonymous], Open-source cheminformatics
[2]   Structure-activity relationships for In vitro and In vivo toxicity [J].
Blagg, Julian .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 41, 2006, 41 :353-368
[3]   Supervised prediction of drug-target interactions using bipartite local models [J].
Bleakley, Kevin ;
Yamanishi, Yoshihiro .
BIOINFORMATICS, 2009, 25 (18) :2397-2403
[4]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[5]   Drug target identification using side-effect similarity [J].
Campillos, Monica ;
Kuhn, Michael ;
Gavin, Anne-Claude ;
Jensen, Lars Juhl ;
Bork, Peer .
SCIENCE, 2008, 321 (5886) :263-266
[6]   Tissue Expression Difference between mRNAs and lncRNAs [J].
Chen, Lei ;
Zhang, Yu-Hang ;
Pan, Xiaoyong ;
Liu, Min ;
Wang, Shaopeng ;
Huang, Tao ;
Cai, Yu-Dong .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
[7]   Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms [J].
Chen, Lei ;
Zhang, Yu-Hang ;
Zhang, Zhenghua ;
Huang, Tao ;
Cai, Yu-Dong .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 10 :57-67
[8]   Inferring anatomical therapeutic chemical (ATC) class of drugs using shortest path and random walk with restart algorithms [J].
Chen, Lei ;
Liu, Tao ;
Zhao, Xian .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (06) :2228-2240
[9]   Gene expression differences among different MSI statuses in colorectal cancer [J].
Chen, Lei ;
Pan, Xiaoyong ;
Hu, XiaoHua ;
Zhang, Yu-Hang ;
Wang, ShaoPeng ;
Huang, Tao ;
Cai, Yu-Dong .
INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (07) :1731-1740
[10]   Identify Key Sequence Features to Improve CRISPR sgRNA Efficacy [J].
Chen, Lei ;
Wang, Shaopeng ;
Zhang, Yu-Hang ;
Li, Jiarui ;
Xing, Zhi-Hao ;
Yang, Jialiang ;
Huang, Tao ;
Cai, Yu-Dong .
IEEE ACCESS, 2017, 5 :26582-26590